What Is Special about the “Human” in “Human Genetics”?*  by Nussbaum, Robert L.
Am. J. Hum. Genet. 76:198–202, 2005
198
2004 ASHG PRESIDENTIAL ADDRESS
What Is Special about the “Human” in “Human Genetics”?*
Robert L. Nussbaum†
Genetic Disease Research Branch, National Human Genome Research Institute, Bethesda
Robert L. Nussbaum
I would like to begin where all of my predecessors as
President have begun, by thanking the membership for
placing their trust and confidence in me to serve as your
President this past year. Serving in this role has given
me a superb bird’s eye view of the organization and the
dedicated and knowledgeable people who work in the
administrative office. I have also had an opportunity to
share the thoughts and wisdom of a remarkable group
of people on the Board of Directors and on the com-
mittees who give their time and energy as volunteers to
our Society. To all of you, I want to express my gratitude
and admiration.
When I began to compose my presidential address, I
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went to the texts of previous presidential addresses and
discovered that it was de´ja` vu all over again: most of
my predecessors had done the same thing and had read
through the comments of previous Presidents to get some
idea of what was expected of them. Most commented
that this review of the “sacred texts” was not as helpful
as they hoped. Why? They found, as did I, that there was
no “formula.” H. J. Muller, Alfred Knudson, Janet Row-
ley, Arthur Beaudet, and David Valle gave scholarly dis-
sertations on scientific areas of personal interest to them
and, they hoped, more broadly to the membership. John
Hamerton, Margery Shaw, and Charlie Epstein spoke
eloquently about important social issues of the day, such
as the controversy over the 47,XYY karyotype and anti-
social behavior, the concepts of wrongful life and wrong-
ful birth, and, most famously, Charlie Epstein’s forceful
reminder that “Not everyone loves human genetics.”
Still others gave personal remembrances, such as Judy
Hall and Hunt Willard, who spoke of their personal
experiences and relationships with mentors and col-
leagues over the years. I did receive some advice from
my adult children to “Keep it short and try to be en-
tertaining.” I at least accomplished one of those goals
(i.e., to keep it short). I donated a good portion of the
time usually allotted to the presidential address to Bren-
dan Lee and the Program Committee so they could
increase the number of presentations at the plenary
session.
I had to face the dilemma of being just one in a long
line of presidents, many of whom were very distinguished
geneticists, true giants in the field. What could I say that
had not already been said? In this dilemma, I was not
alone. There is a wonderful erudite set of essays on 18th
century literature by a college professor of mine, Walter
Jackson Bate, called “The Burden of the Past and the
English Poet,” in which he discusses the problem faced
by poets who had to ply their craft in the footsteps of
the likes of Shakespeare and Dryden. In the introduction
to his essay, he quotes an Egyptian scribe who wrote
4,000 years ago: “Would I had phrases that are not
known, utterances that are strange, in new language that
has not been used, free from repetition, not an utterance
which was spoken by men of old and already grown
stale.”
Don’t we all! So, in trying to find something new to
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say, free from repetition, I decided to go back to the
beginning and review what is written in the charter of
our Society when it was launched, and there wasn’t a
long past history of presidential addresses. The chartered
mission of the Society is
1. to encourage and integrate research, scholarship,
and education in all areas of human genetics,
2. to bring into close contact investigators in the many
general fields of research that involve human ge-
netics, and
3. to encourage discourse on applications of human
genetics to society at large.
The founders of our Society had very ambitious goals,
and continuing to strive toward these goals remains criti-
cal for the continued vitality and relevance of our So-
ciety. They are, however, goals that cannot be achieved
without your help and involvement. I will be giving a
report on how well we, the members of the Society, are
fulfilling the charge and responsibility laid out by its
founders.
Broadly speaking, each component of our mission can
be mapped onto three major activities of our Society:
1. to encourage and integrate research, scholarship,
and education in all areas of human genetics—that’s
our journal,
2. to bring into close contact investigators in the many
general fields of research that involve human ge-
netics—that’s our meeting—and
3. to encourage discourse on applications of human
genetics to society at large—that’s our Policy and
Education Programs, as embodied in the work of
our permanent Executive Vice President, our Men-
tor Network and our Social Issues and Information
and Education Committees.
Each of these activities is healthy, but there is much
still to be done as we face a changing terrain with major
challenges.
First, the journal.
As I am sure you have heard, the entire field of sci-
entific publishing was awoken from its dogmatic slum-
ber by the launch of the Open Access movement. At a
meeting of its proponents held in the Spring of 2003,
two basic principles were enunciated:
1. the author(s) and copyright holder(s) grant(s) to all
users a free, irrevocable, worldwide, perpetual right
of access to, and a license to copy, use, distribute,
transmit, and display the work publicly, and
2. a complete version of the work and all supple-
mental materials is deposited immediately upon
initial publication in at least one appropriate online
repository, to enable open access and unrestricted
distribution.
The real push, however, came this summer, when,
in mid-July, the House Appropriations Committee ap-
proved legislation funding the Department of Health and
Human Services for fiscal year 2005. Accompanying the
bill was a report, with language by Congressman Istook,
ordering the National Institutes of Health to develop a
plan placing an electronic copy of any paper resulting
from NIH-funded research on PubMed Central, the free
digital library maintained by the National Library of
Medicine. As proposed, copies would be available 6
months after their journal publication date or—if the
publication costs were partially paid for by NIH—the
initial manuscript would be available immediately on
PubMed. Soon thereafter, an open letter from 25 Nobel
laureates was sent to Congress in support of the Open
Access Initiative.
The underlying motive of making peer-reviewed sci-
entific literature available electronically, online, without
subscription cost is a laudable goal. The devil is, of course,
in the details.
One issue is financial. The Open Access Initiative says
optimistically, “We can be confident that OA journals
are economically sustainable because the true costs of
peer review, manuscript preparation, and OA dissemi-
nation are considerably lower than the prices we cur-
rently pay for subscription-based journals. Moreover, as
OA spreads, libraries will realize large savings from the
conversion, cancellation, or demise of subscription-based
journals.”
Unfortunately, this statement was more a leap of faith
than a hard-eyed look at the publishing balance sheet.
Our journal already operates successfully with open elec-
tronic access 6 months after publication. If even this small
delay were eliminated, what would happen to paid sub-
scriptions? We should not lose sight of the fact that the
journal is hardly a profit-making operation that is lining
the pockets of fat-cat owners and shareholders. What
profit we make from the journal helps support the ac-
tivities of the Society, including the office, the work of
our committees, the outreach efforts, and all the rest.
The second issue, of where the online electronic ver-
sions are to reside, is also an important one. The Open
Access model makes a strong scientific argument that
“… barrier-free access to the literature also means bar-
rier-free access for the software that facilitates full-text
searching, indexing, mining, summarizing, querying,
linking, alerting, and other forms of processing and
analysis.”
Just as we have open access to genomic data, expres-
sion array data, polymorphism data—just so, we need
open access to the far more complicated but rich data
in the published literature, to allow data mining to sup-
port the computer-assisted analysis that can bring novel
relationships and correlations to light.
We are concerned that PubMed Central may not be
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up to the task of hosting the entire biomedical literature
in electronic form as the sole repository. The National
Library of Medicine claims that it is. The American Jour-
nal of Human Genetics and its publisher, the University
of Chicago Press, have actually had some experience try-
ing to get PubMed Central to post full-text articles from
our journal in a timely manner—our experience did not
build confidence. However, that was in the past, and
PubMed Central’s functioning could always improve.
In a notice published last month, the NIH announced
that it was seeking public comments regarding its plans
to facilitate open access for publications of work sup-
ported by the NIH.
The intent will be for accepted manuscripts to go into
PubMed Central for open access as e-publications im-
mediately on acceptance. This version would be replaced
by the final copy-edited version from the publisher no
more than 6 months after acceptance, with a link to the
publisher’s Web site. The NIH “trusts” that the up-to-
6-month delay will not result in such disruption of cur-
rent journal revenue streams and business models that
unreasonable or disproportionate charges will be made
to grantees.
Open access is an issue to which we all—as authors,
peer reviewers, and members of a society with a valued
journal—must pay attention. The leadership of ASHG is
working to reach a reasonable accommodation that will
serve the public interest without destroying a whole raft
of scholarly journals, including our own.
Now, the meeting. Here, I would like to turn to the
main theme of my address and provide some personal
answers to the question I posed in the title of my talk:
What is special about the “human” in “human genetics”?
Let me remind you of component 2 of the Society’s
mission:
2. to bring into close contact investigators in the
many general fields of research that involve hu-
man genetics.
In his 1977 presidential address, Arno Motulsky wrote,
“The boundaries of human genetics are indistinct and
blurred. It is sometimes said that future progress in the
sciences, particularly in those areas of importance for
human health and welfare, will increasingly come from
interdisciplinary fields by applying concepts and tech-
niques from one field to another area. We must therefore
continue to be on the lookout for methods from other
fields….”
I have been coming to the meetings of the ASHG for
many years because it is the one place where not only
are novel and exciting findings in human genetics pre-
sented, but the attendees care about what these results
mean to patients, their families, society at large, and our
understanding of who we are as a species. The scope of
the meeting is expansive, not narrow. However, new ar-
eas of research important to human genetics continue to
develop and flourish, often through the efforts of many
of our members, yet often largely outside the boundaries
of our meeting. Are we in a position to share in this
information and benefit from it? As a society, we all have
much to learn in areas of inquiry, such as genomics, gene-
replacement technology, stem-cell research, social sci-
ence and behavioral research, communication research,
functional physiological imaging, real-time microscopy,
and translational research in multifactorial risk assess-
ment and intervention. This is not to say that these fields
are entirely neglected at the meeting or that the meeting
is overly occupied with research that is irrelevant to the
field of human genetics. No, my greatest fear is that of
parochialism, in which we continue a system that is sim-
ply a self-perpetuating status quo. If we get set in our
ways, become known for being interested in certain areas
and not others with relevance to human genetics, we
will attract members with research interests that simply
reinforce such conceptions. The result? A self-fulfilling
prophecy that narrows our membership base and sci-
entific scope.
The Board of Directors discussed this issue among
themselves and with the Program Committee and de-
cided on an experiment that we call “Strategic Out-
reach.” We have convened a group of ASHG members
with strong ties to other organizations and fields, to be
headed by Dr. Diana Bianchi from your Board of Di-
rectors. The Strategic Outreach Committee is charged
with organizing a special symposium at the annual meet-
ing, designed to highlight a topic that is pertinent and
relevant but unusual compared with what is currently
presented and discussed at the meeting. The Strategic
Outreach Symposium will be a plenary session and should
highlight unusual areas that are off the beaten path.
What makes this different from the very valuable inter-
disciplinary symposia that our members suggest to the
Program Committee is that we want the symposium to
be primarily, if not exclusively, composed of people from
outside our Society, who may never have attended an
ASHG meeting and yet are doing research that may
prove very important to future progress in our field. Our
success in this endeavor will be measured in a number
of ways: first, by how successful we are in putting to-
gether symposia here that the members find thought pro-
voking and illuminating; second, by whether we en-
courage attendance at our annual meeting by individuals
from these other societies once they encounter the power
and beauty of the field of human genetics; and, third,
by whether we are asked to participate in other annual
meetings to spread the word about human genetics.
Strategic Outreach is doomed to fail, however, with-
out the active involvement of our ASHG membership.
Be active—get in touch with the Strategic Outreach
group so we can take advantage of your knowledge and
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contacts within other societies to help us form partner-
ships. I set this as a challenge to you, the members, to
work with your leadership to make the meeting a place
where we continue to emphasize that the “human” in
“human genetics” is special, because it requires us to be
broad and interdisciplinary if we are going to truly en-
compass the many ways that genetics is informed by and
is applied to human biology, medicine, and society.
How about the third component of our mission?
3. to encourage discourse on applications of human
genetics to society at large.
This aspect of our mission was addressed by Lee Ro-
senberg in his eloquent presidential address in 1980. He
chose to talk about the American Society of Human
Genetics itself, how it was organized, how it was func-
tioning, who were its members. What I found particu-
larly interesting was that his talk occurred at a pivotal
moment in our Society’s history, when we were out-
growing the stage of being a cottage industry run out
of the academic Office of the President and of the journal
publisher. In a memorably succinct understatement, Lee
said, “Our organization is anything but a household
word…. [We face a] fundamental problem—namely, that
of increasing the likelihood that our opinion will be
sought about those matters in the domain of our knowl-
edge and experience.”
He went on to recommend that the ASHG establish
a permanent office in Washington, D.C., and join forces
with other organizations with clout. The Society took
him at his word, although we took our own sweet time
in doing it! In 1983, ASHG/GSA established its own
independent office in the Washington, D.C., area with
its first executive director, Gerry Gurvich, who was then
succeeded by Elaine Strass 9 years later. Nineteen years
after Lee’s speech, we joined FASEB to add our voice to
the strength of all the other members of the Federation.
Twenty-one years after Lee’s talk, Joann Boughman be-
gan as executive vice president to provide a full-time
presence on policy issues in Washington.
Thus, after nearly 20 years of cautious development
and maturation, the Society began to carry out some of
the recommendations first proposed by Lee Rosenberg.
The final point I would like to make is that the third
component of our mission, to encourage discourse on
applications of human genetics to society at large, re-
quires an informed, knowledgeable public. Thus, I want
to emphasize the role we need to play in education,
particularly what we can do to encourage discourse on
applications of human genetics to society at large.
A commitment to education is a duty. The public is
clearly supportive of research. Consistently, polls show
that, when asked if they supported federal funding for
research, over 80% said they did, even among those who
scored highly on a questionnaire designed to measure
levels of reservation about science and technology.
Consistently over the past three decades, when asked
to weigh the benefits and risks of scientific research, be-
tween 70% and 80% of the American public felt that
benefits outweighed risks.
Yet, in the recent NSF survey of public attitudes to-
ward science and technology, half of all adults expressed
an interest in science but did not feel well informed,
whereas only 10% were considered attentive (i.e., they
felt informed and read at least a monthly magazine rele-
vant to some area of science). Society is clearly in favor
of research, yet most of them know very little about
what we do and how we do it.
Informing the public is not, however, a hopeless task.
I draw your attention to a poll, released in February of
last year, of the American public’s knowledge of some-
thing very basic: “What is DNA?”
New Poll Shows Dramatic Rise in Americans’ “DNA
I.Q.”: Threefold Increase Delights Educators, But Is
It Enough?
Richmond, VA, Feb. 27, 2003—A new Harris poll of
a nationally representative sample of 1,031 Americans
released today showed that the “DNA I.Q.” of Ameri-
can adults is much higher than expected. The poll found
that 60% of U.S. adults got the right answer when
asked “What is DNA?” When given the multiple
choice question, “What does DNA stand for?” two
thirds chose deoxyribonucleic acid. The findings show
a dramatic rise in genetics awareness since 1996, when
a National Science Foundation survey showed only
21% of adults could define DNA.
I would love to think that the increasing importance
and visibility of human genetics is responsible for this
rise in what the Richmond Times Dispatch called the
“DNA I.Q.” Is it, perhaps, the Human Genome Project
and all of the attendant publicity? However, according
to the Pew Research Center for the People and the Press,
as reported in the National Science Foundation Report
on Science and Technology: Public Attitudes and Public
Understanding, only 16% of the public claimed to be
following that story very closely. Thus, there may be other
places where people are getting their information. My
favorite candidate is the DNA forensics shown on the
television show Crime Scene Investigation, or CSI.
How can we get involved in education of children
below the undergraduate level, in grades K–12, where
the vast majority of our school-aged children will receive
essentially all the classroom instruction in human ge-
netics they will get for the rest of their lives? We hold
our regular local high school program that precedes our
annual meeting. This all-day workshop is an all-volun-
teer effort by a very dedicated group of individuals, peo-
ple like Paula Gregory, Loraine Omen-Gaines, Susanne
Haga, for whom education is a passion and a calling.
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We also have participated on a regular basis, giving
workshops and lectures to teachers at national confer-
ences of the High School Biology Teachers and the Na-
tional Science Teachers Association. However, we think
we can do more; in particular, we can contribute to
improving the genetics education. I would like to high-
light the “Outreach to Teach” or Mentor Program, which
the Society established and is working to expand.
The mentor program, sponsored jointly by The Ameri-
can Society of Human Genetics, The National Human
Genome Research Institute, The Genetic Alliance, and
the Genetics Society of America, encompasses roughly
1,200 geneticists in the United States, Canada, Mexico,
and 37 other countries who have expressed a willingness
to participate in local educational efforts, such as DNA
Day for the kindergarten-through-the-12th-grade level.
We have worked to inform superintendents, science co-
ordinators, and science and biology teachers of the men-
tor network and educational resources available for use
in the classroom. The ASHG organized a meeting last
month that brought together representatives of major
science teachers’ groups, organizations that provide on-
line educational material for genetics, experts involved
in the Biological Science Curriculum Study textbooks,
and a number of other interested parties. Loraine Omen-
Gaines, of the Information and Education Committee,
was the prime mover and organizer. These discussions,
which have now just begun and are in their infancy, are
designed to establish partnerships between the Society
and educators. There are a number of ways we have
explored involving our Society in the education effort,
including developing a “clearing house” on our Web site
for already-existing age-appropriate, well-vetted educa-
tional material for our mentors to use when they volun-
teer in classrooms, joining state and local networks es-
tablished by the National Science Teachers dedicated
to this effort, to even getting involved in consulting with
textbook companies that put biology textbooks into
thousands and thousands of classrooms around the
country.
This effort is an important part of our mission, but I
also recognize that we are a small organization whose
members volunteer their time and energy to the cause.
We all have full-time jobs already. We have a well-run
meeting and a presence in the hearing rooms and offices
where important public policy is made because we have
wonderful people on our administrative staff who can
focus their energy on the Society’s business. The Board
of Directors has been very supportive in setting aside a
small fund for developing pilot projects in education, as
well as for hiring an additional ASHG staff member to
spearhead an education initiative. If we are to move out
beyond the confines of our meeting and our journal, to
encourage discourse on applications of human genetics
to society at large, as our charter puts it, we need fi-
nancial resources beyond what we currently can muster.
Foundations who might support our efforts will want
us to show that the members are willing to pitch in and
support our efforts by contributing. I am launching a
fund-raising campaign, to form the basis of an effort in
the near future to highlight our initiatives in education
to potential donors, either individual or corporate. To
start this campaign off, I have a pledge from the Board
of Directors to kick-start our campaign. My hope is that
the membership will join in when we come knocking.
The members of this Society are dedicated to exploring
the many ramifications of human genetics research and
informing the public about what we do and why.
Our willingness to embrace interdisciplinary ap-
proaches and our commitment to have an ongoing dia-
logue with policy makers and the public is what’s special
about the “human” in “human genetics.”
Thank you for your attention, and enjoy the rest of
the meeting. I certainly will!
